Evidence map›Paper›PMID 28900774›Full record

SynthesisHeart failure reviews2017

Readmission rate after ultrafiltration in acute decompensated heart failure: a systematic review and meta-analysis.

Waqas Javed Siddiqui, Andrew R Kohut, Syed F Hasni, Jesse M Goldman, Benjamin Silverman, Ellie Kelepouris, Howard J Eisen, Sandeep Aggarwal

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Heart failure reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Ultrafiltration for acute heart failure.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Heart Failure-Focus on Kidney Replacement Therapy: Why, When, and How?International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Waqas Javed SiddiquiDepartment of Medicine, Division of Nephrology and Hypertension, Drexel University College of Medicine, Philadelphia, PA, 19102, USA. dr.waqas20@gmail.com.
Andrew R KohutDepartment of Medicine, Division of Cardiology, Drexel University College of Medicine, Philadelphia, PA, 19129, USA.
Syed F HasniDepartment of Medicine, Division of Cardiology, Drexel University College of Medicine, Philadelphia, PA, 19129, USA.
Jesse M GoldmanDepartment of Medicine, Division of Nephrology and Hypertension, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
Benjamin SilvermanDepartment of Medicine, Division of Cardiology, Drexel University College of Medicine, Philadelphia, PA, 19129, USA.
Ellie KelepourisDepartment of Medicine, Division of Nephrology and Hypertension, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
Howard J EisenDepartment of Medicine, Division of Cardiology, Drexel University College of Medicine, Philadelphia, PA, 19129, USA.
Sandeep AggarwalDepartment of Medicine, Division of Nephrology and Hypertension, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
Drexel University · USHahnemann University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance of ultrafiltration in acute decompensated heart failure remains unclear. We performed meta-analysis to determine its role in reducing readmissions after acute decompensated heart failure. MEDLINE was searched using PUBMED from inception to March 22, 2017 for prospective randomized control trials comparing ultrafiltration to diuretics in acute decompensated heart failure. Five hundred ninety studies were found; nine studies with 820 patients were included. Studies with renal replacement therapy bar ultrafiltration, chronic decompensated heart failure, and non-English language were excluded. RevMan Version 5.3 was used for analysis. The primary outcomes analyzed were cumulative and 90 days readmissions secondary to heart failure and all-cause readmissions. Baseline characteristics were similar. One hundred eighty-eight patients were readmitted with heart failure, 77 vs 111 favoring ultrafiltration; risk ratio (RR) = 0.71 (95% confidence interval (CI), 0.49-1.02, p = 0.07, I

Indexed as

Heart FailureHumansPatient ReadmissionUltrafiltrationDiureticsHeart failureReadmissionUltrafiltration

Identifiers

PMID28900774
OpenAlexW2755711561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.